Abattis Bioceuticals (Abattis Bioceuticals) Other Long-Term Liabilities : $2.69 Mil (As of Sep. 2019)

View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Other Long-Term Liabilities?

Abattis Bioceuticals's other long-term liabilities for the quarter that ended in Sep. 2019 was $2.69 Mil.

Abattis Bioceuticals's quarterly other long-term liabilities increased from Mar. 2019 ($0.00 Mil) to Jun. 2019 ($2.76 Mil) but then declined from Jun. 2019 ($2.76 Mil) to Sep. 2019 ($2.69 Mil).

Abattis Bioceuticals's annual other long-term liabilities stayed the same from Sep. 2017 ($0.00 Mil) to Sep. 2018 ($0.00 Mil) but then increased from Sep. 2018 ($0.00 Mil) to Sep. 2019 ($2.69 Mil).

Abattis Bioceuticals Other Long-Term Liabilities Historical Data

The historical data trend for Abattis Bioceuticals's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Other Long-Term Liabilities Chart

Abattis Bioceuticals Annual Data

Trend

Sep10

Sep11

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Other Long-Term Liabilities

Get a 7-Day Free Trial

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Abattis Bioceuticals Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Abattis Bioceuticals Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6

Website

http://www.abattis.com

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.